In light of these two recent studies, it may be postulated that ovarian cancers lacking the expression of these claudins show a more aggressive and metastatic behavior, which contradicts the previously accepted concept that claudin-3 or claudin-4 overexpression in ovarian carcinoma is related to a more malignant phenotype of ovarian cancer. This evidence concerns the gene CLDN3 and ovarian cancer.